Related Experiment Video
Updated: Jul 8, 2026
05:31
Gas Chromatography-Mass Spectrometry Paired with Total Vaporization Solid-Phase Microextraction as a Forensic Tool
Published on: May 25, 2021
Gamma-hydroxybutyric acid (GHB) withdrawal: a case report
W R Murray Bennett1, Lawrence G Wilson, Peter P Roy-Byrne
1Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine at Harborview Medical Center, Seattle, WA 98104, USA. mbennett@u.washington.edu
Journal of Psychoactive Drugs
|December 28, 2007
Summary
Gamma-hydroxybutyrate (GHB) withdrawal can be severe and resistant to standard benzodiazepine treatment. This study highlights successful management using atypical neuroleptics, suggesting a novel therapeutic approach for difficult GHB withdrawal cases.
Area of Science:
- Neuroscience
- Pharmacology
- Addiction Medicine
Background:
- Gamma-hydroxybutyrate (GHB) is a prevalent substance of abuse.
- GHB dependence can lead to a severe withdrawal syndrome.
- Benzodiazepines are the standard treatment for GHB withdrawal.
Observation:
- Some GHB withdrawal cases are resistant to benzodiazepine treatment.
- A case of benzodiazepine-resistant GHB withdrawal was observed.
- Initial treatment with benzodiazepines was unsuccessful.
Findings:
- Successful treatment of benzodiazepine-resistant GHB withdrawal was achieved with adjuvant atypical neuroleptics.
- A potential neurochemical mechanism for the efficacy of atypical neuroleptics in GHB withdrawal is proposed.
Implications:
- Atypical neuroleptics may offer an effective alternative for managing severe, benzodiazepine-resistant GHB withdrawal.
- Further research into the neurochemical underpinnings of GHB withdrawal is warranted.
- This finding could guide clinical practice for complex substance withdrawal cases.
Related Concept Videos
01:21Hyperosmolar Hyperglycemic State
Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:25Diabetic Ketoacidosis l: Introduction
DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
01:30Generalized Anxiety Disorder
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...